 GKOS | Glaukos Corp Company profile
Company profileWe are an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. We have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. We launched the iStent®, our first MIGS device, in the United States in July 2012 and launched our next-generation iStent inject® device in the United States in September 2018. We are leveraging our platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.
Address229 Avenida Fabricante | NotesJump to (Finance sites)          ResearchInvestor pageinvestors.glaukos.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite.
Their Official Profiles Peers / Similar stocks Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk. Take advantage of price swings in strongly trending securities and pump up your portfolio! |
